Vitamin D deficiency and
adipocytokines have been implicated in the etiology of aging-related diseases such as
cancer,
osteoporosis, and diseases of the cardiovascular system. The association between elevated
parathyroid hormone (PTH) and low
25-hydroxyvitamin D (25-OH-VitD) in plasma is used to define
vitamin D deficiency, yet their associated mechanistic pathways are unclear. Utilizing plasma samples from women in a previous intervention study, we measured plasma 25-OH-VitD,
leptin,
adiponectin, PTH, and
lipid levels. We observed strong positive associations for
leptin with PTH,
gamma -tocopherol, and body mass index (BMI) and inverse associations with 25-OH-VitD and
adiponectin. Although commonly accepted that
vitamin D deficiency causes
hyperparathyroidism, we observed this association primarily in individuals with elevated
leptin levels, suggesting that
leptin may be an important modifier of this effect consistent with 25-OH-VitD-mediated inhibition of
leptin.
Leptin was highly correlated with the BMI/25-
OH-VitD ratio (r = 0.80; P < 0.0001), consistent with a model in which BMI (adiposity) and 25-OH-VitD are the primary determinants of circulating
leptin and PTH levels. This model may explain the failure of some studies to observe elevated PTH in
vitamin D deficient adolescents and provides important insight into epidemiological studies exploring the associations of these individual
biomarkers with
chronic disease risk and mortality.